Use of Trichomonas vaginalis clinical isolates to evaluate correlation of gene expression and metronidazole resistance

Journal of Parasitology

Volumn 92, Issue 1, 2006, Pages 196-199

  Mead, J R ^a,b   Fernadez, M ^a,b   Romagnoll, P A ^a,b   Secor, W E ^c  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERREDOXIN; MALATE DEHYDROGENASE (DECARBOXYLATING); MESSENGER RNA; METRONIDAZOLE; PYRUVATE SYNTHASE;

ANOXIC CONDITIONS; CORRELATION; DRUG RESISTANCE; ENZYME; GENE EXPRESSION; PARASITE; RNA;

AEROBIC METABOLISM; ANAEROBIC METABOLISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; TRICHOMONAS VAGINALIS;

ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; DNA PRIMERS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GENES, RRNA; HUMANS; HYDROGENASE; METRONIDAZOLE; POLYMERASE CHAIN REACTION; PYRUVATE SYNTHASE; RNA, MESSENGER; STATISTICS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

TRICHOMONAS VAGINALIS;

EID: 33645552904     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-616R.1     Document Type: Article

References (22)

1. BROWN, D. M., J. A. UPCROFT, H. N. DODD, N. CHEN, AND P. UPCROFT. 1999. Alternative 2-keto acid oxidoreductase activities in Trichomonas vaginalis. Molecular and Biochemical Parasitology 98: 203-214.
2. BUVE, A., H. A. WEISS, M. LAGA, E. VAN DYCK, R. MUSONDA, L. ZEKENG, M. KAHINDO, S. ANAGONOU, L. MORISON, N. J. ROBINSON, AND R. J. HAYES (STUDY GROUP ON HETEROGENEITY OF HIV EPIDEMICS IN AFRICAN CITIES). 2001. The epidemiology of trichomoniasis in women in four African cities. AIDS 15: S89-S96.
3. CHESSON, H. W., J. M. BLANDFORD, AND S. D. PINKERTON. 2004. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sexually Transmitted Disease 31: 547-551.
4. DIAMOND, L. S. 1957. The axenic cultivation of various trichomonads of animals and man. Journal of Parasitology 43: 488-490.
5. EDWARDS, D. 1993. Nitroimidazole drugs action and resistance mechanisms I. Mechanisms of action. Journal of Antimicrobial Chemotherapy 31: 9-20.
6. ELLIS, J. E., D. COLE, AND D. LLOYD. 1992. Influence of oxygen on the fermentative metabolism of metronidazole-sensitive and resistant strains of Trichomonas vaginalis. Molecular Biochemical Parasitology 56: 79-88.
7. KULDA, J. 1999. Trichomonas, hydrogenosomes and drug resistance. International Journal for Parasitology 29: 199-212.
8. LAND, K. M., D. L. CLEMENS, AND P. J. JOHNSON. 2001. Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonds. Experimental Parasitology 97: 102-110.
9. -, M. G. DELGADILLO-CORREA, J. TACHEZY, S. VANACOVA, C. L. HSIEH, R. SUTAK, AND P. J. JOHNSON. 2004. Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance. Molecular Microbiology 51: 115-122.
10. LLOYD, D., N. YARLETT, AND N. C. YARLETT. 1986. Inhibition of hydrogen production in drug-resistant and susceptible Trichomonas vaginalis strains by a range of nitroimidazole derivatives. Biochemical Pharmacology 35: 61-64.
11. MEINGÄSSNER, J. G., L. HAVELEC, AND H. MIETH. 1978. Studies on strain sensitivity of Trichomonas vaginalis to metronidazole. British Journal of Venereal Diseases 54: 72-76.
12. NARSICI, E. M., AND W. E. SECOR. 1996. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrobial Agents and Chemotherapy 40: 1121-1125.
13. PETRIN, D., K. DELGATY, R. BHATT, AND G. GARBER. 1998. Clinical and microbiological aspects of Trichomonas vaginalis. Clinical Microbiology Reviews 2: 300-317.
14. QUON, D. V., C. E. D'OLIVEIRA, AND P. J. JOHNSON. 1992. Reduced transcription of the ferrodoxin gene in metronidazole-resistant Trichomonas vaginalis. Proceedings of the National Academy of Sciences USA 89: 4402-4406.
15. RASOLOSON D., E. TOMKOVA, R. CAMMACK, J. KULDA, AND J. TACHEZY. 2001. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen. Parasitology 123: 45-56.
16. -, S. VANACOVA, E. TOMKOVA, J. RAZGA, I. HRDY, J. TACHEZY, AND J. KULDA. 2002. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Microbiology 148: 2467-2477.
17. SNIPES, L. J., P. M. GAMARD, E. M. NARCISI, C. B. BEARD, T. LEHMANN, AND W. E. SECOR. 2000. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. Journal of Clinical Microbiology 38: 3004-3009.
18. SOBEL, J. D., V. NAGAPPAN, AND P. NYIRJESY. 1999. Metronidazole-resistant vaginal trichomoniasis-An emerging problem. New England Journal of Medicine 341: 292-293.
19. SORVILLO, F., AND P. KERNDT. 1998. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351: 213-214.
20. UPCROFT, P., AND J. A. UPCROFT. 2001. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clinical Microbiology Reviews 14: 150-164.
21. VOOLMANN, T., AND P. BOREHAM. 1993. Metronidazole resistant Trichomonas vaginalis in Brisbane. Medical Journal of Australia 159: 490.
22. YARLETT, N., N. C. YARLETT, AND D. LLOYD. 1986. Ferrodoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis. Biochemical Pharmacology 35: 1703-1708.